Lumvoa (veligrotug-vvze)

Approved for To treat thyroid eye disease. 12.1 Mechanism of Action Veligrotug-vvze's mechanism of action in patients with thyroid eye disease has not been fully characterized. Veligrotug-vvze is a humanized IgG1 monoclonal antibody that… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from FDA labels, openFDA FAERS, and CMS NADAC pricing.

Loading full data from Know Your Drugs Institute…